DOPAMINE HYDROCHLORIDE

N/A

Manufactured by Deseret Biologicals, Inc.

8,648 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DOPAMINE HYDROCHLORIDE

DOPAMINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Deseret Biologicals, Inc.. The most commonly reported adverse reactions for DOPAMINE HYDROCHLORIDE include DRUG INEFFECTIVE, HYPOTENSION, OFF LABEL USE, CARDIAC ARREST, RENAL FAILURE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DOPAMINE HYDROCHLORIDE.

Top Adverse Reactions

DRUG INEFFECTIVE599 reports
HYPOTENSION383 reports
OFF LABEL USE274 reports
CARDIAC ARREST200 reports
RENAL FAILURE196 reports
ACUTE KIDNEY INJURY194 reports
CONDITION AGGRAVATED160 reports
SEPSIS146 reports
DEATH142 reports
PNEUMONIA142 reports
PYREXIA140 reports
RESPIRATORY FAILURE135 reports
DYSPNOEA134 reports
RENAL IMPAIRMENT134 reports
DIARRHOEA131 reports
TOXICITY TO VARIOUS AGENTS131 reports
BRADYCARDIA129 reports
CARDIAC FAILURE121 reports
DRUG INTERACTION112 reports
ANAEMIA110 reports
METABOLIC ACIDOSIS107 reports
PAIN107 reports
SHOCK105 reports
VOMITING104 reports
BLOOD PRESSURE DECREASED103 reports
CARDIOGENIC SHOCK103 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME101 reports
NAUSEA98 reports
MULTI ORGAN FAILURE88 reports
SEPTIC SHOCK88 reports
RENAL FAILURE ACUTE85 reports
THROMBOCYTOPENIA79 reports
PLATELET COUNT DECREASED78 reports
PULMONARY OEDEMA77 reports
HAEMOGLOBIN DECREASED76 reports
OVERDOSE75 reports
ANXIETY74 reports
ASTHENIA74 reports
BLOOD CREATININE INCREASED72 reports
HYPERTENSION71 reports
VENTRICULAR TACHYCARDIA71 reports
FATIGUE70 reports
CARDIO RESPIRATORY ARREST68 reports
TACHYCARDIA68 reports
GENERAL PHYSICAL HEALTH DETERIORATION67 reports
HYPOXIA67 reports
ALANINE AMINOTRANSFERASE INCREASED65 reports
BLOOD UREA INCREASED65 reports
INTENTIONAL OVERDOSE65 reports
LACTIC ACIDOSIS65 reports
THERAPY NON RESPONDER65 reports
SEIZURE64 reports
INJURY63 reports
PLEURAL EFFUSION63 reports
RENAL INJURY63 reports
CARDIAC FAILURE CONGESTIVE61 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION61 reports
UNEVALUABLE EVENT60 reports
HYPOKALAEMIA58 reports
ATRIAL FIBRILLATION57 reports
FALL57 reports
VENTRICULAR FIBRILLATION57 reports
DISSEMINATED INTRAVASCULAR COAGULATION56 reports
BLOOD GLUCOSE INCREASED55 reports
DIZZINESS55 reports
HEPATIC FUNCTION ABNORMAL55 reports
PULMONARY HYPERTENSION54 reports
LOSS OF CONSCIOUSNESS53 reports
ABDOMINAL DISTENSION52 reports
FOETAL EXPOSURE DURING PREGNANCY52 reports
RHABDOMYOLYSIS52 reports
ABDOMINAL PAIN51 reports
ASPARTATE AMINOTRANSFERASE INCREASED51 reports
COMA51 reports
DEPRESSED LEVEL OF CONSCIOUSNESS50 reports
FEAR50 reports
MYOCARDIAL INFARCTION49 reports
STRESS49 reports
EMOTIONAL DISTRESS48 reports
PRODUCT USE ISSUE48 reports
ELECTROCARDIOGRAM QT PROLONGED47 reports
LYMPHOCYTE COUNT DECREASED47 reports
WHITE BLOOD CELL COUNT INCREASED46 reports
HYPERKALAEMIA45 reports
PRODUCT USE IN UNAPPROVED INDICATION45 reports
ACUTE RESPIRATORY FAILURE44 reports
ANURIA43 reports
PULMONARY EMBOLISM43 reports
DEPRESSION42 reports
PULMONARY HAEMORRHAGE42 reports
HAEMODYNAMIC INSTABILITY41 reports
URINARY TRACT INFECTION41 reports
COAGULOPATHY40 reports
ANHEDONIA39 reports
CHEST PAIN39 reports
DECREASED APPETITE39 reports
DISEASE PROGRESSION39 reports
GASTROINTESTINAL HAEMORRHAGE39 reports
HEPATIC FAILURE39 reports
MATERNAL EXPOSURE DURING PREGNANCY39 reports

Report Outcomes

Out of 3,680 classified reports for DOPAMINE HYDROCHLORIDE:

Serious 95.1%Non-Serious 4.9%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male1,745 (53.1%)
Female1,526 (46.4%)
Unknown15 (0.5%)

Reports by Age

Age 6865 reports
Age 6162 reports
Age 7561 reports
Age 6959 reports
Age 5557 reports
Age 7052 reports
Age 6050 reports
Age 7150 reports
Age 349 reports
Age 5849 reports
Age 6648 reports
Age 5947 reports
Age 6747 reports
Age 146 reports
Age 6246 reports
Age 7344 reports
Age 4943 reports
Age 6543 reports
Age 6442 reports
Age 241 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DOPAMINE HYDROCHLORIDE?

This profile reflects 8,648 FDA FAERS reports that mention DOPAMINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DOPAMINE HYDROCHLORIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, HYPOTENSION, OFF LABEL USE, CARDIAC ARREST, RENAL FAILURE, ACUTE KIDNEY INJURY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DOPAMINE HYDROCHLORIDE?

Labeling and FAERS entries often list Deseret Biologicals, Inc. in connection with DOPAMINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.